Haematological abnormalities in mitochondrial disorders.

Area of Science:

• Hematology
• Genetics
• Rare Diseases

Background:

• Mitochondrial disorders (MIDs) are a group of complex genetic conditions affecting cellular energy production.
• Hematological abnormalities are recognized but not fully characterized in patients with MIDs.

Purpose of the Study:

• To investigate the types and frequency of hematological abnormalities in patients diagnosed with mitochondrial disorders.
• To establish the diagnostic significance of blood count variations in MIDs.

Main Methods:

• Retrospective review of blood cell counts in a cohort of syndromic and non-syndromic MID patients.
• Classification of MIDs into 'definite', 'probable', and 'possible' categories based on clinical, biochemical, and genetic data.
• Exclusion of patients with other identifiable causes for hematological abnormalities.

Main Results:

• Hematological abnormalities attributable to MIDs were identified in 46 patients.
• Anemia was the most frequent abnormality (78.3%), often occurring as the sole hematological issue.
• Other observed abnormalities included thrombopenia (13.0%), leucopenia (8.7%), and eosinophilia (8.7%), sometimes in combination with anemia.

Conclusions:

• Abnormal blood cell counts, particularly anemia, thrombopenia, leucopenia, or eosinophilia, warrant consideration for MIDs when other causes are ruled out.
• Hematological findings can be the primary or a secondary manifestation of mitochondrial disorders.
• These findings highlight the importance of hematological evaluation in the diagnostic workup of suspected MIDs.